Mohsen Ghafouri, MD
Rheumatology · Manassas, VANPI 1912929233
Payments from drug & device makers
Across 701 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$5K
- Johnson & Johnson$2K
- Amgen$2K
- AbbVie$2K
- Novartis$1K
- Pfizer$1K
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 1 | $5,000 |
| Johnson & Johnson(2 entities) | 151 | $2,429 |
| Amgen(2 entities) | 106 | $2,199 |
| AbbVie | 92 | $2,134 |
| Novartis | 50 | $1,110 |
| Pfizer | 73 | $1,030 |
| Mallinckrodt Hospital Products Inc. | 31 | $1,014 |
| UCB, Inc. | 32 | $765 |
| E.r. Squibb & Sons, L.L.C. | 28 | $564 |
| GSK | 22 | $507 |
| Mallinckrodt Enterprises LLC | 9 | $388 |
| Lilly USA, LLC | 17 | $284 |
| Bristol Myers Squibb | 20 | $264 |
| Genentech USA, Inc. | 16 | $243 |
| AstraZeneca(2 entities) | 9 | $170 |
| ANI Pharmaceuticals, Inc. | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $130 |
| Radius Health, Inc. | 6 | $114 |
| Fresenius Kabi USA, LLC | 3 | $82 |
| Aurinia Pharma U.S., Inc. | 3 | $70 |
| Edwards Lifesciences | 3 | $65 |
| Sobi, Inc | 3 | $61 |
| Cumberland Pharmaceuticals, Inc. | 2 | $51 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Merck | 2 | $24 |
| Sandoz | 1 | $24 |
| Organon | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Sanofi | 1 | $15 |
How this compares
$19,046 in reported general payments places this provider in the 85th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Manassas
- Gineth Pinto-PatarroyoManassas$61K
- Wayne BaileyManassas$18K
- Parita VasaManassas$7K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
- Kristi MizelleNewport News$1.2M
- Phillip KempfArlington$467K
- Adegbenga BankoleRoanoke$355K
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.